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Objective: The mechanism of spinal cord injury is believed to be related to the
vulnerability of spinal motor neuron cells against ischemia. We tested whether
MCI-186, which is useful for treating ischemic damage in the brain, can protect
against ischemic spinal cord damage.
Methods: After induction of ischemia, MCI-186 or vehicle was injected intrave-
nously. Cell damage was analyzed by observing the function of the lower limbs and
by counting the number of motor neurons. To investigate the mechanism by which
MCI-186 prevents ischemic spinal cord damage, we observed the immunoreactivity
of Cu/Zn superoxide dismutase, neuronal nitric oxide synthase, and endothelial
nitric oxide synthase.
Results: MCI-186 eased the functional deficits and increased the number of motor
neurons after ischemia. The induction of neuronal nitric oxide synthase was signif-
icantly reduced by the treatment with MCI-186. Furthermore, the increase in the
induction of endothelial nitric oxide synthase and Cu/Zn superoxide dismutase was
more pronounced.
Conclusion: These results indicate that MCI-186 may protect motor neurons from
ischemic injury by reducing neuronal nitric oxide synthase and increasing endothe-
lial nitric oxide synthase. MCI-186 may be a strong candidate for use as a thera-
peutic agent in the treatment of ischemic spinal cord injury.
Spinal cord injury after successful operation on the thoracic aorta is adisastrous and unpredictable complication in human beings. In anattempt to prevent this complication, various methods of spinal cordprotection have been suggested,1-3 including temporary shunts, partialbypass, and systemic or regional hypothermia. Regardless of thesurgical technique or method of spinal cord protection used, no
method has been developed that totally prevents the development of paraplegia.4
The reported prevalence of paraplegia ranges from 2.3% to 23% in operations on the
thoracic aorta.5 The mechanism of spinal cord injury during operations on the
thoracic aorta is believed to be related primarily to direct tissue ischemia. Ischemia
can occur when there is permanent exclusion of the essential intercostal arterial
blood supply to the spinal cord or temporary interruption of the spinal cord blood
flow.6,7 Spinal motor neurons are believed to be more vulnerable to ischemia than
dorsal horn neurons, but the reason for this difference is not fully understood. To
investigate the exact mechanism of the vulnerability of spinal motor neurons to
ischemia, we created a reproducible model of spinal cord ischemia in which we
statistically analyzed cell damage.8,9
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Our previous report, in which we examined rabbit spinal
cords immunohistochemically after 15 minutes of transient
ischemia, demonstrated that neuronal nitric oxide (NO)
synthase (nNOS), endothelial NO synthase (eNOS), and
Cu/Zn superoxide dismutase (SOD) are induced to in-
creased levels in motor neurons.10 In rabbits, the death of
motor neurons after 15 minutes of ischemia is caused by
apoptosis. The mechanism of cytotoxicity may be associ-
ated with NOS.10 NO is a free gas that is synthesized from
arginine by NOS, and highly induced NOS results in the
production of too much NO. NO reacts with superoxide and
produces the powerful oxidant peroxynitrite (ONOO). Re-
cently, it has been suggested that NO and ONOO may
cause oxidative damage. Cu/Zn SOD acts as a radical scav-
enger, so it has a neuroprotective effect. However, Cu/Zn
SOD reacts with peroxynitrite to form nitrotyrosine, and too
much accumulation of nitrotyrosine may be more harmful to
motor neurons.11,12 The induction of too much nNOS
causes neurons to die. However, eNOS protects against
transient ischemic damage even if the mechanism is not
known.13 Nevertheless, nNOS, eNOS, and Cu/Zn SOD
might be useful markers for investigating the mechanism of
neuronal death after spinal cord ischemia.11
MCI-186 inhibits a peroxidative mechanism in vitro14
and markedly protects against ischemic and postischemic
brain edema in rats, perhaps by scavenging hydroxy and
peroxyl radicals.15 However, the possibility that MCI-186 is
effective in protecting motor neurons of the spinal cord
from ischemic injury has not yet been examined. In this
study, we investigated the protective effect of MCI-186
after transient ischemia and showed that MCI-186 reduces
the distribution of nNOS, increases the distribution of eNOS
and Cu/Zn SOD, and protects spinal cord motor neurons
from ischemic injury.
Materials and Methods
Animal Models
Thirty-three male domesticated white rabbits (Kumagai Company,
Sendai, Japan), weighing 2 to 3 kg, were divided into 3 groups:
sham control group, transient ischemia and treatment with vehicle
group (group I), and transient ischemia and treatment with MCI-
186 group (group M). All rabbits were allowed free access to food
and water before and after the procedure, and they were treated in
accordance with the Declaration of Helsinki and the Guidelines for
the Care and Use of Laboratory Animals. The experimental and
animal care protocols were approved by the Animal Care Com-
mittee of the Tohoku University School of Medicine.
Anesthesia was induced with intramuscular administration of
ketamine at a dose of 50 mg/kg and maintained with 2% halothane
inhalation in oxygen. A 5F pediatric balloon-tipped catheter
(model 405; Braun, Melsungen, Germany) was inserted through
the right femoral artery and advanced 15 cm forward into the
abdominal aorta. Preliminary experiments had already confirmed
that the balloon in the distal end of the catheter should be posi-
tioned 0.5 to 1.5 cm distal to the left renal artery.16 The catheter
was immediately removed without injection or balloon inflation in
the sham control animals. In groups I and M, spinal cord ischemia
was achieved by the inflation of the balloon to obstruct blood flow
to the spinal cord as previously described.16 Our previous exper-
iments confirmed that 15 minutes of transient spinal cord ischemia
is sufficient to result in selective motor neuron death.8,9 Saline
(vehicle, 1 mL/kg rabbit body weight) or MCI-186 (3 mg/mL
saline/kg rabbit body weight) was administered intravenously after
30 minutes of reperfusion. Immediately after the animals died, the
spinal cord was quickly removed with the plunger of a 1-mL
syringe.17 All samples were frozen in powdered dry ice and stored
at 80°C until use. Then the spinal cords were cut transversely at
approximately the L2 or L3 level and mounted on glass slides.
Neurologic Assessment
Neurologic function was assessed before the animals were killed 8
hours, 1 day, 2 days, or 7 days (n  3 at 8 hours, 1, or 2 days; n
 5 at sham, 7 days) after reperfusion. Animals were classified by
a 5-point scale devised by Johnson and colleagues as follows: 0 
hind-limb paralysis; 1  severe paraparesis; 2  functional move-
ment, no hop; 3  ataxia, uncoordinated hop; 4  minimal ataxia;
and 5 normal function.18 Two individuals without knowledge of
the treatment independently graded neurologic function. The
Mann-Whitney U test was used to compare the neurologic scores
and cell numbers.
Histologic Study
The sections taken 7 days after reperfusion in both groups were
stained with hematoxylin-eosin and examined by light microscopy.
An observer who was unaware of the animal group or neurologic
outcome examined each slide. With hematoxylin-eosin staining,
the cells were considered dead if the cytoplasm was diffusely
eosinophilic and viable if the cells showed basophilic stripping
(contained Nissel substance).19 The Mann-Whitney U test was
used to compare the neurologic scores and cell numbers.
Immunohistochemistry
A mouse monoclonal anti-Cu/Zn SOD antibody (sc8637, 1:200
dilution; Santa Cruz Biotechnology Associates Inc, Santa Cruz,
Calif), a mouse monoclonal anti-nNOS antibody (sc5302, 1:200
dilution; Santa Cruz Biotechnology Associates Inc), and a mouse
monoclonal anti-eNOS antibody (SA-258, 1:200 dilution; BI-
OMOL Research Laboratories, Plymouth Meeting, Pa) were used
for immunohistochemical studies. For the immunohistochemical
analysis, the sections were fixed for 10 minutes in ice-cold ace-
tone, air dried, and rinsed in 0.01 mol/L phosphate buffer contain-
ing 0.15 mol/L NaCl (pH 7.4). After being blocked with 10%
normal horse serum for 2 hours, the slides were washed and
incubated overnight at 4°C with a mouse monoclonal antibody.
Endogenous peroxidase was blocked for 20 minutes with 0.3%
H2O2 and 10% methanol. Then, sections were washed and incu-
bated for 3 hours with biotinylated anti-mouse immunoglobulin G
(1:200 dilution; PK6102, Vector Laboratories, Burlingame, Calif)
in the buffer, followed by incubation for 30 minutes with an
avidin-biotin-peroxidase complex (PK6102). Staining was devel-
oped with 3,3'-diaminobenzidine tetrahydrochloride (0.5 mg/mL in
50 mmol/L Tris-HCl buffer, pH 7.4) in the presence of H2O2.
Staining was categorized in 4 grades in the following manner: no
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staining (), slight staining (), moderate staining (), or dense
staining (2). The results are expressed as the mean  the SD of
the mean. The Mann-Whitney U test was used to compare the
neurologic scores and cell numbers.
Results
Neurologic Assessment
The neurologic results are summarized in Table 1. All of the
rabbits survived until they were killed. All sham-operated
controls (n  5) demonstrated normal neurologic function
(score of 5). Both group I (n  14) and group M (n  14)
were divided into their individual reperfusion times (8
hours, 1 day, 2 days, and 7 days). All rabbits in group I
demonstrated severe paraparesis by 7 days to a score of less
than 3 points (n  5). All group M rabbits demonstrated
almost normal function after the procedure. There was a
significant difference in physiologic function between group
I and group M animals 7 days after the procedure as as-
sessed by the Mann-Whitney U test (P  .02).
Histologic Study
The numbers of intact motor neurons are summarized in
Table 2. In sham-operated control animals, the spinal cord
was intact with many large motor neurons in the anterior
horn (AH) (Figure 1). However, 7 days after blood flow
restoration in group I, more than 70% of the motor neurons
in the spinal cord were damaged. Seven days after reperfu-
sion in group M, there was less evidence of damaged motor
neurons. The number of intact motor neurons in group I was
significantly smaller than in group M (P  .009) (Table 2).
Immunohistochemical Study
Table 3 is a summary of the immunohistochemical analysis
in each group. The motor neurons in the AHs of sham-
operated rabbits were slightly positive for Cu/Zn SOD.
Whereas the Cu/Zn SOD immunoreactivity was induced in
the motor neurons of group M with a peak at 2 days, it was
only slightly induced at 2 days in group I (Figure 2). Other
neurons such as dorsal neurons and glial cells did not show
any significant inductions (data not shown). The motor
neurons in the AHs of sham controls were slightly positive
for eNOS. The eNOS immunoreactivity was strongly in-
duced in the motor neurons of group M at 2 days; con-
versely, it was only slightly induced at 2 days in group I
(Figure 3).
The antibody for nNOS only slightly labeled the motor
neurons in the AHs of the sham controls. The nNOS im-
munoreactivity was strongly induced in the motor neurons
of group I at 8 hours and 1 day, whereas it was only slightly
induced in group M (Figure 4, Table 3).
TABLE 1. Neurologic functional scores on the seventh day
after the procedure
Animal Sham Group I Group M
1 5 2 3
2 5 2 3
3 5 3 5
4 5 2 5
5 5 3 5
Mean  SD 5 2.4  0.5 4.2  1.1
P  .02 compared with the scores during group I: Mann-Whitney test.
TABLE 2. Numbers of large motor neurons in the ventral
gray matter on the seventh day after the procedure
Animal Sham Group I Group M
1 23 6 16
2 21 6 17
3 22 8 14
4 19 7 19
5 21 8 15
Mean  SD 21.2  1.5 7.0  1.0 16.2  1.9
P  .008 compared with the sham control group: Mann-Whitney test.
P  .009 compared with group I: Mann-Whitney test.
Figure 1. Histologic findings of the spinal cord 7 days after 15
minutes of ischemia; stained with hematoxylin-eosin. The spinal
cord of sham-control (A) was intact. In the spinal cord of group I
(B), more than 70% of motor neurons were lost; motor neurons
indicate eosinophilic changes. Seven days after reperfusion in
group M (C), there was less evidence of damaged motor neurons,
and no glial changes were found. Motor neurons (black arrows).
Bar  400 m.
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TABLE 3. Immunoreactivity for Cu/Zn SOD, nNOS, and eNOS in the spinal motor neuron
CU/Zn SOD nNOS eNOS
Sham control   
Group I Group M Group I Group M Group I Group M
8 h   22   
1 d  2    
2 d  222    222
7 d      
Group I, Transient ischemia group; group M, transient ischemia and treatment with MCI-186 group; , negative; , subtle positive reaction; , positive
reaction; 2 strongly enhanced reaction.
SOD, Superoxide dismutase; nNOS, neuronal nitric oxide synthase; eNOS, endothelial nitric oxide synthase.
Figure 2. Immunohistochemical staining for Cu/Zn superoxide
dismutase (SOD) in spinal cord at sham (A), 8 hours (B), 1 day (C),
and 2 days (D) after ischemia in group I and at 8 hours (E), 1 day
(F), and 2 days (G) after ischemia in group M. The Cu/Zn SOD
immunoreactivity in group I was only slightly induced at 2 days.
The density of Cu/Zn SOD immunoreactivity in group M was
stronger than that in group I at 2 days. Motor neurons staining
strongly with Cu/Zn SOD (black arrows). Bar  400 m.
Figure 3. Immunohistochemical staining for endothelial nitric
oxide synthase (eNOS) in spinal cord at sham (A), 8 hours (B), 1
day (C), and 2 days (D) after ischemia in group I and at 8 hours (E),
1 day (F), and 2 days (G) after ischemia in group M. The eNOS
immunoreactivity in group I was only slightly induced at 2 days.
The density of eNOS immunoreactivity in group M was stronger
than that in group I at 1 and 2 days. Motor neurons staining
strongly with eNOS (black arrows). Bar  400 m.
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Discussion
MCI-186 is known to inhibit a peroxidative mechanism in
vitro, and peroxidative mechanisms have been implicated in
ischemic and postischemic cell damage.20 There are 2 path-
ways for generating peroxidative reactions in the damaged
brain, as there are in any tissue: auto-oxidation (nonenzy-
matic peroxidation) and enzyme-processing peroxidation.21
Cell damage induced by nonenzymatic peroxidation within
an in vitro system is suspected to be attributable to iron,
SOD, hydrogen peroxide, and lipoxygenase products from
arachidonic acid (enzyme-processing peroxidation).22
It is widely appreciated that, in a middle cerebral artery
occlusion model, a marked increase in water content at the
ischemic area may be the result of an increase in water
supply resulting from reperfusion and may correspond to
the potential for tissue swelling.14 Furthermore, marked
generation of superoxide derived from arachidonate metab-
olism may also worsen the cell damage and result in the
aggravation of brain edema during reperfusion.23 The intro-
duction of arachidonate or a potent initiator of free radicals
leads to brain edema in vivo.24 Recent reports showed that
MCI-186 markedly attenuates ischemic and postischemic
brain in rats.14 We therefore tested whether MCI-186 has a
preventive effect in the AH of the spinal cord after transient
ischemia. Treatment with MCI-186 resulted in preservation
of paraplegia and demonstrated a protective effect on motor
neurons.
Immunoreactivity for Cu/Zn SOD is slightly positive in
the motor neurons of the AH under normal conditions25 and
is induced in rabbit spinal cords after 15 minutes of transient
ischemia, with a peak at 24 hours after reperfusion.10 Both
nNOS and eNOS are slightly present in the motor neurons
in the AH. In this study, nNOS was induced by transient
ischemic insult with a peak at 8 hours of reperfusion, as was
eNOS with a peak at 24 to 48 hours.
MCI-186 increased the expression of eNOS but de-
creased that of nNOS. Although both nNOS and eNOS
introduced NO, each had a different effect on motor neu-
rons.26 Our findings demonstrate that overexpression of
nNOS results in neuronal death, whereas increased intro-
duction of eNOS has a neuroprotective effect. Thus, it is
suggested that moderate production of NO by eNOS has an
apparent neuroprotective effect, and that overproduction of
NO by nNOS induces neurotoxicity.13 Therefore, MCI-186
inhibits ischemic damage to motor neurons by both reduc-
ing the neurotoxic factor nNOS and increasing the neuro-
protective factor eNOS. MCI-186 may also have the effect
of increasing the expression of Cu/Zn SOD. Cu/Zn SOD
may work as a radical scavenger to protect neurons from
ischemic damage.
Many reports of experiments in vitro and in vivo have
suggested that MCI-186 reacts with hydroxy and peroxyl
radicals by scavenging, whereas there has been little evi-
dence that MCI-186 inhibits the activity of NO in ischemic
tissue.21 However, we hypothesize that MCI-186 also re-
duces the degree of cell damage in ischemic spinal cords by
scavenging the free radicals that superoxide, NO, and
ONOO are believed to easily become. A previous report
showed that MCI-186 reduces the activity of endothelium-
derived NO.27 Our results indicate that MCI-186 may react
with NO and ONOO directly or may scavenge the free
radicals induced by them.
Amyotrophic lateral sclerosis (ALS) is a motor neuron
disease characterized by relatively selective degeneration of
motor neurons in the spinal cord, brain stem, and motor
cortex. Approximately 10% of ALS is familial, and the
remainder is sporadic.28 Recently, mutations in the Cu/Zn
SOD gene were identified in a number of patients with
Figure 4. Immunohistochemical staining for neuronal nitric oxide
synthase (nNOS) in spinal cord at sham (A), 8 hours (B), 1 day (C),
and 2 days (D) after ischemia in group I and at 8 hours (E), 1 day
(F), and 2 days (G) after ischemia in group M. The nNOS immu-
noreactivity in group I was strongly induced at 8 hours. The
density of nNOS immunoreactivity in group M was less strong
than that in group I at 8 hours. Motor neurons staining strongly
with nNOS (black arrows). Bar  400 m.
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familial ALS29 and are believed to be a result of the cyto-
toxicity of the mutant Cu/Zn SOD protein. The cytotoxicity
of nitrotyrosine is currently suspected in the mechanism of
motor neuron death in ALS.30 Recent studies showed that
nitrotyrosine increased in transgenic mice with familial
ALS mutations.27 Both in the brain and spinal cord, once
ischemic change occurs, the amount of NO is highly in-
creased because nNOS is highly induced.10,24 NO reacts
with superoxide to produce the powerful oxidant ONOO,
whereas Cu/Zn SOD reacts with peroxynitrite to form ni-
trotyrosine.11,12 Furthermore, in the present study, we dem-
onstrated that MCI-186 reduces nNOS but induces eNOS
and normal Cu/Zn SOD. Therefore, we suspect that the
amount of nitrotyrosine with MCI-186 induction may be
reduced in the spinal cord after transient ischemia, and our
results indicate that the mechanism of motor neuron death in
the spinal cord after ischemia may have a feature in com-
mon with familial ALS.
Conclusion
This report shows that MCI-186 protects the motor neurons
of the spinal cord from ischemic injury. MCI-186 reduces
the induction of nNOS and increases that of both eNOS and
Cu/Zn SOD. MCI-186 should be a strong candidate for use
as a therapeutic agent in the treatment of ischemic spinal
cord injury in the near future.
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